RxDoctor Payments Data

Alexandra Nix, PA

Physician Assistant · Williamsport, PANPI 1073048161

Payments from drug & device makers

$1,131in general payments, 2019–2025

Across 62 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$567
  • GSK$118
  • Abbott$101
  • Lilly USA, LLC$81
  • Novo Nordisk$65
  • Johnson & Johnson$45
  • plus $153 from 8 others

What the payments were for

  • Food & beverage$1,131100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,131 in reported general payments places this provider in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$116,697
Medicare patients
251
Services billed
1,879

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban113$89,528
OzempicSemaglutide88$87,785
TradjentaLinagliptin79$49,364
JardianceEmpagliflozin51$39,542
XareltoRivaroxaban39$33,590
TrulicityDulaglutide26$24,442
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$21,957
MounjaroTirzepatide17$21,743
JanuviaSitagliptin Phosphate21$21,660
MyrbetriqMirabegron35$20,489
Breo ElliptaFluticasone/Vilanterol29$17,382
RexultiBrexpiprazole13$16,247
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$9,314
PremarinEstrogens, Conjugated21$6,681
Tresiba Flextouch U-200Insulin Degludec11$6,600

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$28$96,209134 claims
Novo NordiskOzempic$65$87,78588 claims
Lilly USA, LLCTrulicity, Mounjaro$81$46,18543 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$118$42,63069 claims
Johnson & JohnsonXarelto$45$33,59039 claims
AbbVieSynthroid$567$4,29666 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Williamsport

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →